Novita Pharmaceuticals
PrivateLast Round
Strategic
Jul 28, 2021
Total Funding Raised
$25.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Novita Pharmaceuticals operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Strategic round in July 2021.
Novita Pharmaceuticals is a biopharmaceutical company that develops first-in-class drugs to prevent and treat cancer metastasis and enhance anti-cancer immune responses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novita Pharmaceuticals Comparables
Compare Novita Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| China Resources Pharmaceutical Group Ltd | 78% | |
| Pacylex Pharmaceuticals | 73% | |
| Cybrexa Therapeutics | 72% |
For institutional investors. Book with your work email.
Novita Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 28, 2021 | ||||
| Debt | Oct 16, 2020 | ||||
| Series A | Apr 6, 2017 | ||||
| Seed | Jan 4, 2011 |
For institutional investors. Book with your work email.
Novita Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Asia | Series A |
| Gaorong Capital | Debt, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 32% MoM.
- Jul 25, 2026
Monthly visitors increased 57% MoM, reaching 2.9K.
For institutional investors. Book with your work email.
Novita Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novita Pharmaceuticals's valuation, stock price, and market status.
Is Novita Pharmaceuticals a public or private company?
Novita Pharmaceuticals is a private company.
What is the current stock price of Novita Pharmaceuticals?
Novita Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Novita Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novita Pharmaceuticals worth (valuation)?
Valuation information for Novita Pharmaceuticals is not publicly available.
Can I buy Novita Pharmaceuticals stock?
Novita Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novita Pharmaceuticals's last funding round?
Novita Pharmaceuticals's most recent funding round was Strategic on July 28, 2021.
Who are the main investors in Novita Pharmaceuticals?
Key investors in Novita Pharmaceuticals include Bain Capital Asia, Gaorong Capital.
Will Novita Pharmaceuticals IPO soon?
No public IPO plans have been announced for Novita Pharmaceuticals.
How can I track Novita Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Novita Pharmaceuticals's shares on secondary markets.